Exhaled Breath Analysis for Investigating the Use of Inhaled Corticosteroids and Corticosteroid Responsiveness in Wheezing Preschool Children.
Michiel A G E BannierSophie KienhorstQuirijn JöbsisKim D G van de KantFrederik-Jan van SchootenAgnieszka SmolinskaEdward DompelingPublished in: Journal of clinical medicine (2022)
Exhaled breath analysis has great potential in diagnosing various respiratory and non-respiratory diseases. In this study, we investigated the influence of inhaled corticosteroids (ICS) on exhaled volatile organic compounds (VOCs) of wheezing preschool children. Furthermore, we assessed whether exhaled VOCs could predict a clinical steroid response in wheezing preschool children. We performed a crossover 8-week ICS trial, in which 147 children were included. Complete data were available for 89 children, of which 46 children were defined as steroid-responsive. Exhaled VOCs were measured by GC- tof -MS. Statistical analysis by means of Random Forest was used to investigate the effect of ICS on exhaled VOCs. A set of 20 VOCs could best discriminate between measurements before and after ICS treatment, with a sensitivity of 73% and specificity of 67% (area under ROC curve = 0.72). Most discriminative VOCs were branched C 11 H 24 , butanal, octanal, acetic acid and methylated pentane. Other VOCs predominantly included alkanes. Regularised multivariate analysis of variance (rMANOVA) was used to determine treatment response, which showed a significant effect between responders and non-responders ( p < 0.01). These results show that ICS significantly altered the exhaled breath profiles of wheezing preschool children, irrespective of clinical treatment response. Furthermore, exhaled VOCs were capable of determining corticosteroid responsiveness in wheezing preschool children.
Keyphrases
- young adults
- clinical trial
- cystic fibrosis
- randomized controlled trial
- climate change
- study protocol
- open label
- electronic health record
- risk assessment
- mass spectrometry
- phase ii
- artificial intelligence
- single molecule
- phase iii
- big data
- smoking cessation
- liquid chromatography
- placebo controlled
- high speed
- tandem mass spectrometry
- neural network